Gathering Strength to Soar, Winning the New Era with Intelligence | JoinStar 2026 West Lake Summit Concludes Successfully!

May in Hangzhou brings the fragrance of loquats and insightful industry dialogues. On May 23, the JoinStar 2026 West Lake Summit was grandly held in Hangzhou. Industry experts and partners from across the nation gathered to explore policy trends, technological innovations, cooperative growth, and the new blueprint for the digital and intelligent transformation of the IVD industry.

Centered on policy guidance, technological innovation, practical implementation, and ecosystem synergies, the summit comprehensively showcased JoinStar’s latest achievements in R&D, product matrices, market strategies, and its role as an AI-powered chronic disease management solution provider.

01. Policy Navigation: Clarifying New Industry Directions

The conference opened with a deep dive into policies and industry analysis, parting the mist and charting a clear course for all partners.

JoinStar Chairman Zhou Xuyi delivered a keynote speech titled "Breakthrough and Growth: The Path to Win-Win Cooperation in the New Era." He conducted an in-depth review of the IVD industry's four-year adjustment cycle, noting that 2026 marks a period of stabilization and an approaching turning point for recovery. Chairman Zhou emphasized that JoinStar remains steadfast in its positioning as the leading solution provider for organ dysfunction trends management. By prioritizing cost reduction and efficiency as the foundation, and revenue growth as the primary goal, JoinStar is committed to building a sustainable, profitable ecosystem with its partners.

Guest speakers, including Honggeng Lu, Senior Vice President of the Healthcare Industry Group at GF Securities, and Guangyu Li, General Manager of IVD Network, provided comprehensive analyses on the IVD industry's investment value, commercial pathways, and operational optimizations. Their insights offered partners clear, actionable strategies to navigate the current industry cycle, lower trial-and-error costs, and secure sustainable, long-term growth.

02. Core Innovation: Unveiling the iMatrix Prime Fully Automated Analyzer

Innovation is the core driver of enterprise development. A major highlight of the summit was the new product launch ceremony for the iMatrix Prime Fully Automated Flow Fluorescence Immunoassay Analyzer.

Representing a milestone in JoinStar's commitment to proprietary R&D, the iMatrix Prime utilizes our advanced multiplex assay liquid chip platform. With its fully automated, high-throughput, and rapid testing capabilities, it turns "hundred-level multiplex testing" from a concept into reality.

Simultaneously showcased was the JC220L CLIA analyzer, equipped with the pioneering "True Whole Blood" CLIA system. This technology allows for direct whole-blood processing from the original tube, significantly reducing turnaround times (TAT) and providing emergency departments and primary care facilities with a comprehensive solution to cut costs, increase speed, and boost efficiency.

03. Practical Empowerment: Paving the Path for Market Growth

Continuing the tradition of "letting those who hear the gunfire make decisions," the market strategy session was packed with actionable insights.

JoinStar's marketing and academic teams detailed solutions for emergency departments and highlighted specialized, differentiated test items such as HBP, ST2, and Cytokines. Partners and product managers also explored vast opportunities in early tumor screening (colorectal cancer), multiplex cytokine testing, and comprehensive panels for allergens and food intolerance.

Real-world case studies from leading hospitals and regional centers were presented, demonstrating highly effective and replicable models for hospital compliance, POCT integration, and regional lab network solutions. These proven methodologies provide partners with a complete toolkit for channel expansion and continuous profitability.

04. Business Model Innovation: A New AI+IVD Ecosystem

Focusing on digital intelligence and mutual success, the AI+IVD session redefined the logic of industry growth.

As an AI-powered chronic disease management solution provider, JoinStar showcased how a dual-driven "technology + operations" approach resolves clinical pain points. With successful implementations across over 50 districts and 800 medical institutions nationwide, this digital ecosystem enhances primary care visits, testing volumes, and patient health metrics. Presentations highlighted how smart billing, full-cycle follow-ups, and data visualization are helping partners transition from product suppliers to intelligent operational service providers.

05. Strategic Synergy: Embarking on a New Journey Together

JoinStar officially released its 2026 Channel Strategy and Cooperation Support Plan, establishing a tiered partner cultivation system. Through targeted policy responses, optimized market layouts, and service upgrades, JoinStar is injecting long-term momentum into its partnerships.

The summit also featured an annual partner award ceremony, presenting the Excellence Award, Breakthrough Award, and Evergreen Award to recognize outstanding partners for their long-term dedication and remarkable achievements.

06. Conclusion: Gathering Strength to Soar Together

In his closing remarks, Chairman Zhou Xuyi summarized the summit's achievements and reinforced the company's unwavering determination to advance alongside its national partners. The event concluded successfully amidst the joyous and collaborative atmosphere of the evening gala.

Gathering strength to soar, living up to the era; winning the new era with intelligence, creating brilliance together! JoinStar looks forward to seeing you again next year!